文献速递流行病学与生物统计组学、生物样本库与精准医学

脂蛋白A及其他血脂与前列腺癌风险的关系:一项多变量孟德尔随机化研究

The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study.
PubMed 文献 · PLoS Med · 2022-01-27

该研究利用UK Biobank和PRACTICAL联盟的全基因组关联研究数据,采用两样本汇总水平孟德尔随机化方法,评估遗传预测的血脂浓度与前列腺癌风险的关联。研究发现遗传预测的脂蛋白A浓度与前列腺癌总风险升高相关,而HDL、TG、apoA和apoB未见关联,LDL的关联在调整其他血脂后消失。

要点

  • 遗传预测的脂蛋白A浓度与前列腺癌总风险升高相关(多变量IVW OR每SD=1.068)。
  • 遗传预测的HDL、TG、apoA和apoB浓度与前列腺癌风险无关联。
  • 遗传预测的LDL浓度在单变量分析中与总前列腺癌正相关,调整HDL、TG和脂蛋白A后关联消失。

核心结论

  • 遗传预测的脂蛋白A浓度与前列腺癌风险升高相关。
  • 未来研究需理解该发现的潜在生物学通路,可能通过降低脂蛋白A策略为前列腺癌预防提供信息。

研究设计与样本

  • 两样本汇总水平孟德尔随机化研究,采用单变量和多变量模型,并使用多种稳健方法和敏感性分析评估孟德尔随机化假设违反的可能性。
  • 数据来源:低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、甘油三酯、载脂蛋白A和B、脂蛋白A来自UK Biobank的全基因组关联研究;前列腺癌数据来自PRACTICAL联盟。

主要发现

  • 遗传预测的HDL、TG、apoA和apoB浓度与前列腺癌风险无关联。
  • 遗传预测的LDL浓度在单变量分析中与总前列腺癌正相关,但调整HDL、TG和脂蛋白A后关联为零。
  • 遗传预测的脂蛋白A浓度在单变量分析中与总前列腺癌风险升高相关(加权中位数OR每SD=1.091;95%CI 1.028至1.157;P=0.004),调整其他血脂特征后多变量分析仍相关(IVW OR每SD=1.068;95%CI 1.005至1.134;P=0.034)。
  • 遗传预测的脂蛋白A浓度与晚期前列腺癌相关(多变量IVW OR每SD=1.078;95%CI 0.999至1.163;P=0.055)。
  • 遗传预测的脂蛋白A浓度与早发年龄前列腺癌相关(多变量IVW OR每SD=1.150;95%CI 1.015至1.303;P=0.028)。

局限性

  • 尽管使用了多种估计方法以最小化多效性的影响,但不能排除任何未测量的多效性存在,可能限制研究结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Numerous epidemiological studies have investigated the role of blood lipids in prostate cancer (PCa) risk, though findings remain inconclusive to date. The ongoing research has mainly involved observational studies, which are often prone to confounding. This study aimed to identify the relationship between genetically predicted blood lipid concentrations and PCa. METHODS AND FINDINGS: Data for low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides (TG), apolipoprotein A (apoA) and B (apoB), lipoprotein A (Lp(a)), and PCa were acquired from genome-wide association studies in UK Biobank and the PRACTICAL consortium, respectively. We used a two-sample summary-level Mendelian randomisation (MR) approach with both univariable and multivariable (MVMR) models and utilised a variety of robust methods and sensitivity analyses to assess the possibility of MR assumptions violation. No association was observed between genetically predicted concentrations of HDL, TG, apoA and apoB, and PCa risk. Genetically predicted LDL concentration was positively associated with total PCa in the univariable analysis, but adjustment for HDL, TG, and Lp(a) led to a null association. Genetically predicted concentration of Lp(a) was associated with higher total PCa risk in the univariable (ORweighted median per standard deviation (SD) = 1.091; 95% CI 1.028 to 1.157; P = 0.004) and MVMR analyses after adjustment for the other lipid traits (ORIVW per SD = 1.068; 95% CI 1.005 to 1.134; P = 0.034). Genetically predicted Lp(a) was also associated with advanced (MVMR ORIVW per SD = 1.078; 95% CI 0.999 to 1.163; P = 0.055) and early age onset PCa (MVMR ORIVW per SD = 1.150; 95% CI 1.015,1.303; P = 0.028). Although multiple estimation methods were utilised to minimise the effect of pleiotropy, the presence of any unmeasured pleiotropy cannot be excluded and may limit our findings. CONCLUSIONS: We observed that genetically predicted Lp(a) concentrations were associated with an increased PCa risk. Future studies are required to understand the underlying biological pathways of this finding, as it may inform PCa prevention through Lp(a)-lowering strategies.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Ioannidou A, Watts EL, Perez-Cornago A, et al. The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study. PLoS Med. 2022. PMID: 35085228. doi:10.1371/journal.pmed.1003859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。